» Articles » PMID: 34765498

Multiple Organ Involvement and ICU Considerations for the Care of Acute Liver Failure (ALF) and Acute on Chronic Liver Failure (ACLF) in Children

Overview
Journal Transl Pediatr
Specialty Pediatrics
Date 2021 Nov 12
PMID 34765498
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Liver disease results in approximately 15,000 pediatric hospitalizations per year in the United States and is a significant burden to child health. Major etiologies of liver failure and indications for transplantation in children include: biliary atresia, metabolic/genetic conditions, toxins, infections, tumors, and immune-mediated liver/biliary injury. Children requiring transplantation are placed on the United Network of Organ Sharing waitlist including those with acute liver failure (ALF) and acute on chronic liver failure (ACLF). ALF is a clinical syndrome in which a previously healthy child develops rapid-onset hepatic dysfunction, and becomes critically ill with multiple organ dysfunction within days. ACLF, by contrast, is generally described as an acute decompensation of pre-existing chronic liver disease (CLD) brought on by a precipitating event, with higher risk of mortality. Children with ALF and ACLF receive multidisciplinary care in pediatric intensive care units (ICUs) due to multiple organ system involvement and high risk of decompensation in these patients. The care of these patients requires a holistic approach that addresses the complex interplay between hepatic and extra-hepatic organ systems. This review will define and describe ALF and ACLF in the pediatric population, and outline the effects of ALF and ACLF on individual organ systems with diagnostic and management considerations in the ICU while awaiting liver transplantation.

Citing Articles

Extracorporeal Therapies in Children with Acute Liver Failure: A Single-Center Experience.

Gun E, Durak A, Botan E, Pervane S, Gurbanov A, Balaban B Turk J Gastroenterol. 2022; 34(1):73-79.

PMID: 36445055 PMC: 9985061. DOI: 10.5152/tjg.2022.22062.


Severe Epistaxis in the Pediatric Patient: A Simulation for Emergency Department Management.

Gorbatkin O, Pearce J, Goldschmidt M, Thomas A, Sanseau E, Ciener D Cureus. 2022; 14(8):e27784.

PMID: 36106282 PMC: 9451106. DOI: 10.7759/cureus.27784.


Translating scientific evidence into the art of caring for critically ill children across the globe.

Lee J, Long D, Srinivasan V Transl Pediatr. 2021; 10(10):2643-2645.

PMID: 34765490 PMC: 8578783. DOI: 10.21037/tp-21-429.

References
1.
Squires Jr R, Shneider B, Bucuvalas J, Alonso E, Sokol R, Narkewicz M . Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006; 148(5):652-658. PMC: 2662127. DOI: 10.1016/j.jpeds.2005.12.051. View

2.
Young S, Kwarta E, Azzam R, Sentongo T . Nutrition assessment and support in children with end-stage liver disease. Nutr Clin Pract. 2013; 28(3):317-29. DOI: 10.1177/0884533612474043. View

3.
Chan-Dominy A, Rahiman S, Anders M, Butt W . Extracorporeal membrane oxygenation and severe portopulmonary hypertension following liver transplantation: brief report. Int J Artif Organs. 2015; 38(6):337-42. DOI: 10.5301/ijao.5000410. View

4.
OLeary J, Reddy K, Garcia-Tsao G, Biggins S, Wong F, Fallon M . NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018; 67(6):2367-2374. DOI: 10.1002/hep.29773. View

5.
Krowka M, Fallon M, Kawut S, Fuhrmann V, Heimbach J, Ramsay M . International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation. 2016; 100(7):1440-52. DOI: 10.1097/TP.0000000000001229. View